A vaccine for lung cancer using exosomes from stem cells
A lung cancer vaccine based on exosomes of induced pluripotent stem cells
['FUNDING_R21'] · UNIVERSITY OF LOUISVILLE · NIH-10651014
This study is testing a new lung cancer vaccine made from tiny particles that could help your immune system recognize and fight lung tumors while being safe for healthy cells, and it’s looking for patients to join the trials.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF LOUISVILLE (nih funded) |
| Locations | 1 site (LOUISVILLE, UNITED STATES) |
| Trial ID | NIH-10651014 on ClinicalTrials.gov |
What this research studies
This research investigates a novel lung cancer vaccine that utilizes exosomes derived from induced pluripotent stem cells (iPSCs). The approach aims to target multiple tumor-associated antigens that are present in lung tumors but absent in normal tissues, potentially enhancing the vaccine's effectiveness. By leveraging the similarities between iPSCs and tumor cells, the study will explore how these exosomes can stimulate the immune system to attack lung tumor-initiating cells. Patients may be involved in trials to assess the safety and efficacy of this innovative vaccine.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults at risk for or diagnosed with lung cancer.
Not a fit: Patients with lung cancer who have already undergone extensive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective vaccine for preventing lung cancer.
How similar studies have performed: While there have been attempts to develop lung cancer vaccines, this approach using iPSC-derived exosomes is relatively novel and has not been extensively tested.
Where this research is happening
LOUISVILLE, UNITED STATES
- UNIVERSITY OF LOUISVILLE — LOUISVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LI, CHI — UNIVERSITY OF LOUISVILLE
- Study coordinator: LI, CHI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers